Radiopharm Theranostics annual operating margin
2023
2024
2025
Radiopharm Theranostics's operating margin was −1,050.63% for fiscal 2025.
View full Radiopharm Theranostics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | −1,050.63% | +14726.59 pp |
| 2024 | 2024-06-30 | −15,777.22% | −3981.08 pp |
| 2023 | 2023-06-30 | −11,796.15% | — |
Between the periods ended 2023-06-30 and 2025-06-30, Radiopharm Theranostics's operating margin increased from −11,796.15% to −1,050.63%, a change of +10745.52 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Radiopharm Theranostics source filings ↗